US Brand Name(s): Zepzelca
Use in Cancer Treatment
Lurbinectedin is to treat the following conditions:
Small cell lung cancer that has spread to other parts of the body. It is also for individuals whose illness has worsened during or after platinum chemotherapy treatment.
The FDA’s Accelerated Approval Program has authorised this usage. A confirmatory study (or trials) must prove that lurbinectedin has a therapeutic benefit in these individuals as a condition of approval.
Detailed scientific definition- Definition from the NCI Drug Dictionary
Lurbinectedin Facts on MedlinePlus
A summary of key information regarding this medication in layman’s terms, which may contain the following:
- Cautions about this medicine
- What is the use and how?
- Whom should you consult before taking it?
- What you should know about it before using it?
- Other drugs that might interact with it
- Possible negative effects
Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are being investigated.
